Slide 1: Second Quarter / First Half Year Results 2025
Second Quarter / First Half Year Results 2025 Analyst presentation Investor Relations 31.07.2025
Slide 2: Disclaimer
2 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Disclaimer This presentation contains certain statements that are the Company’s ability to continue to receive adequate neither reported financial results nor other historical products from its vendors on acceptable terms
Slide 3: Group performance
CLARIANT™ Zz Group performanc
Slide 4: Highlights Q2 / H1 2025 Key messages
4 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Highlights Q2 / H1 2025 Key messages – Q2: Improved profitability in challenging market environment Key Figures in CHF ▪ Sales flat in LC – significant FX translation impact (in CHF - 8 %) ✓ EBITDA b.e.i.1 up 200 bps from
Slide 5: Q2 sales: Flat in LC, driven by pricing and volume
5 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Q2 sales: Flat in LC1, driven by pricing and volume – CA volume growth compensating for slightly lower CC2 volumes 0% -8% 1 056 1 056 3 -3 0 - 13 - 75 968 flat flat -1% -7% Care Chemicals Care Chemicals Net impact on Main
Slide 6: Q2 EBITDA b.e.i. margin improvement driven by CA and AA
6 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Q2 EBITDA b.e.i.:1 200 bps margin improvement driven by CA and AA with CC2 flat; reported margin impacted by restructuring EBITDA + 3 % Margin + 200 bps 169 18.8 % 164 2 7 17.5 % CHF 22 m 15.5 % - 11 7 restructuring Other
Slide 7: Business performance
Business performance
Slide 8: Second Quarter 2025 Highlights Care Chemicals
8 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Second Quarter 2025 Highlights Care Chemicals in CHF m Q2 2025 Q2 2024 % CHF % LC1 – Volume slightly down, as strong performance in Crop Sales 497 565 - 12 -2 Solutions and Mining and slight growth in Industrial EBITDA 68
Slide 9: Second Quarter 2025 Highlights Catalysts
9 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Second Quarter 2025 Highlights Catalysts in CHF m Q2 2025 Q2 2024 % CHF % LC1 – Expected strong sequential improvement (+ 39 % LC) Sales 218 222 -2 5 after slow start in Q1 but also year-on-year 5 % LC growth EBITDA 49 44
Slide 10: Second Quarter 2025 Highlights Adsorbents & Additives
10 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Second Quarter 2025 Highlights Adsorbents & Additives in CHF m Q2 2025 Q2 2024 % CHF % LC1 – Volume flat; Additives slightly growing vs. strong comparable Sales 253 269 -6 1 with Coatings & Adhesives and Polymer Solution
Slide 11: Investor Day 2024 savings program set to deliver CHF 80 m by 2027
11 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Investor Day 2024 savings program set to deliver CHF 80 m by 2027 Savings achievement Q1: CHF 3 m Run-rate savings of CHF 80 m through – Total CHF 12 m (Q1 CHF 3 m, Q2 CHF 9 m) Q2: CHF 9 m BU and Corporate actions by 202
Slide 12: First Half Year 2025 Highlights
12 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 First Half Year 2025 Highlights Key Figures in CHF – Sales organically flat in LC as slightly lower volumes (- 1 %) were offset by pricing (+ 1 %), scope added 1 % while currencies impacted by – 5 %. Volumes slightly low
Slide 13: Outlook
Outlook ~ Greater chemistry
Slide 14: Outlook 2025: Confirmed strong commitment to margin improvement
14 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Outlook 2025: Confirmed strong commitment to margin improvement despite slightly lower top-line growth as industrial production weakens 2025 External Factors Internal Factors – Continued weakness in global GDP, tariffs –
Slide 15: Appendix
CLARIANT™
Slide 16: Outlook: Current assessment of tariffs shows manageable direct impacts
16 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Outlook: Current assessment of tariffs shows manageable direct impacts due to global footprint and local-for-local strategy Region Local Local Raw Material Production Sourcing ➔ Current assessment of tariffs shows manage
Slide 17: Modeling Guidance FY 2025 versus FY 2024
17 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Modeling Guidance FY 2025 versus FY 2024 – under current conditions • CHF 25 m sales impact (actual Q1) Acquisition • On-track profitability with acquisition business case Lucas Meyer Cosmetics • Scope effect in Q1 2025
Slide 18: Second Quarter 2025 – Overview
18 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Second Quarter 2025 – Overview Group Care Chemicals in CHF m Q2 2025 Q2 2024 % CHF % LC1 in CHF m Q2 2025 Q2 2024 % CHF % LC1 Sales 968 1 056 -8 0 Sales 497 565 - 12 -2 EBITDA 139 166 - 16 EBITDA 68 98 - 31 EBITDA margin
Slide 19: First Half Year 2025 – Overview
19 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 First Half Year 2025 – Overview Group Care Chemicals in CHF m H1 2025 H1 2024 % CHF % LC1 in CHF m H1 2025 H1 2024 % CHF % LC1 Sales 1 981 2 070 -4 1 Sales 1 096 1 146 -4 2 EBITDA 291 339 - 14 EBITDA 185 221 - 16 EBITDA
Slide 20: First Half Year 2025 – Consolidated Income Statement Highlights
20 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 First Half Year 2025 – Highlights Consolidated Income Statement CHF m 2025 2024 – Gross Margin slightly lower at 29.6 %, driven by slightly CHF m % CHF m % Sales 1 981 100.0 2 070 100.0 increased raw material / energy co
Slide 21: First Half Year 2025 – Cash Flow Statement Highlights
21 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 First Half Year 2025 – Highlights Cash Flow Statement CHF m 2025 2024 Net income 44 176 Adjustment for: Depreciation and amortization 123 119 – Cash generated from operating activities slightly increased to CHF 116 m - i
Slide 22: First Half Year 2025 – Balance Sheet
22 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 First Half Year 2025 – Balance Sheet 30.06.2025 31.12.2024 30.06.2025 31.12.2024 ASSETS CHF m % CHF m % EQUITY AND LIABILITIES CHF m % CHF m % Non-current assets Equity Property, plant, and equipment 1 385 1 524 Share ca
Slide 23: Geographic split Regional headline (Q2)
23 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Geographic split Regional headline Q2 sales CHF 968 m – EMEA sales down 2 %, driven by volumes. Adsorbents & in CHF m, % in local currency1 Additives with positive volumes and pricing. Care Chemicals with lower volumes a
Slide 24: Geographic split Regional headline (H1)
24 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Geographic split Regional headline H1 sales CHF 1 981 m – EMEA sales up 2 %, driven by volume and scope in Care in CHF m, % in local currency1 Chemicals, while Catalysts and Adsorbents & Additives were flat in volumes an
Slide 25: EBITDA / EBIT Bridge First Half Year 2025
25 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 EBITDA / EBIT Bridge First Half Year 2025 Group (CHF m) Care Chemicals (CHF m) EBITDA Exceptional Exceptional EBITDA Exceptional Exceptional bei items EBITDA D&I1 EBITA Amortization EBIT items EBIT bei bei items EBITDA D
Slide 26: ROIC vs. cost of capital Future improvement drivers
26 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 ROIC vs. cost of capital Future improvement drivers ROIC1 in % 3 − Organic growth 10.6 % 9.9 % 4 Cost of 9.5 % 9.2 % capital: 7.7 % 2 − Increasing operating margin 7.4 % ~ 8.0 % 6.6 % − Reducing nonoperating cost − Impro
Slide 27: Cost dynamics – year on year and sequentially slightly up
27 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Cost dynamics – year on year and Q2 2025: Pricing slightly up and sequentially slightly up volumes slightly down (Catalysts) − Raw materials in Q2 increased 1 % yoy (sequential down 1 %) − Uncertain economic environment
Slide 28: Exposure to attractive consumer markets of close to 50%
28 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Exposure to attractive consumer markets of close to 50 %... …with accelerating demand for sustainable products Sales by End Market 2021 (Total Group) Sales by End Market Q2 LTM 20251 Chemical Chemical Process Process Con
Slide 29: ESG – Clariant's Sustainability Transformation Commitment
29 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 ESG – Clariant’s Sustainability Transformation Commitment Sustainability priorities Investment in operations and portfolio Fighting Climate Change Increasing Circularity Sustainable operations Reducing our own carbon Pro
Slide 30: Significant improvement of non-financial KPIs
30 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Significant improvement of non-financial KPIs – Fully on track to deliver updated 2030 greenhouse gas (GHG) targets Reducing corporate GHG emissions New operating model driving customer satisfaction and 46.9 % reduction
Slide 31: Clariant's Leading Sustainability Ratings and Rankings
31 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Clariant’s Leading Sustainability Ratings and Rankings Status as of July 2025 Index / Ranking / Clariant Score / Percentile First Year of Status / Comments Rating Rank or Range Inclusion 29% 21% 13% 15% 10% AA / Range: A
Slide 32: Calendar of Upcoming Corporate Events
32 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 Calendar of Upcoming Corporate Events 30 October 2025 1 April 2026 Third Quarter / Annual General Nine Month 2025 Meeting Reporting 31 July 2025 26 February 2026 Second Quarter / Fourth Quarter / First Half Year 2025 Ful
Slide 33: The Executive Leadership Team
33 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 The Executive Leadership Team Conrad Keijzer Chief Executive Officer Executive Leadership Team Executive Steering Committee Christian Vang Jens Cuntze Angela Cackovich Oliver Rittgen Priya Thaman Judith Bischof Richard H
Slide 34: IR Contacts
34 Second Quarter / First Half Year Results 2025 Investor Relations, 31.07.2025 IR Contacts ANDREAS SCHWARZWÄLDER Head of Investor Relations Phone: +41 61 469 63 73 Email: investor-relations@clariant.com THIJS BOUWENS Investor Relations Officer Phone: +41 61 469 63 73 Email: investor-relations@clari
Slide 35: Thank you
Thank you